比如，和誉医药的第二代FGFR小分子抑制剂ABSK061，在降低对FGFR1抑制的同时，保持对FGFR2/3高选择性，理论上安全性更高。在动物模型中，ABSK061的表现优于Infigratinib，目前ABSK061治疗3-12岁ACH儿童患者的2期临床正在进行中。
syntax = "proto3"; // 指定使用proto3版本
。业内人士推荐爱思助手下载最新版本作为进阶阅读
The web platform has incredible documentation compared to most tech platforms. However, most of it is written for JavaScript. If you don’t know JavaScript, you’ll have a much harder time understanding how to use most Web APIs.
Current and former employees of Google and OpenAI are invited to sign. We verify every signature to ensure authenticity. You may sign anonymously.